USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

Some of these cancerous mutations in DNA are inherited, while others arise from errors that occur as a cell divides.

Abbott (NYSE: ABT) today announced new study data demonstrating the safety and efficacy of its Volt pulsed field ablation ...

In a world where free, infinite, and invisible solar panels are changing the energy sector, we are saying goodbye to the more ...

One of the most frustrating things about working in Microsoft Word is dealing with pictures. They always seem to mess up the ...

Abbott (NYSE: ABT) has announced new data from its Volt CE Mark Study that show strong safety and efficacy out to 12 months ...

Its main business covers a variety of fields, from basic research to commercial applications, with a focus on induced pluripotent stem cell technology, regenerative medicine applications and the ...

The future of medicine will belong to the physicians who are empowered, not sidelined, by technology. And to the patients who ...

Bloom Energy and Equinix are joining forces to push data center sustainability to the next level, rolling out hydrogen fuel ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson’s disease. The papers, published in Nature, investigate the use of cells derived from human ...

InfiniClone is a biotechnology company focusing on the field of regenerative medicine. Its main business covers a variety of fields, from basic research to commercial applications, with a focus on ...